Table 5.
Number of Complications in Binary Variables of Interest in Both Models
| Dataset Type | Variable | Any Complication | No Complications |
|---|---|---|---|
| Full Dataset | |||
| Fluid Administration | 109 | 161 | |
| No Fluid Load | 20 | 78 | |
| Oral Surgery | 4 | 18 | |
| None | 125 | 221 | |
| Neurosurgery | 3 | 20 | |
| None | 126 | 219 | |
| Reduced Dataset | |||
| Obstetrics/Gynecology | 8 | 5 | |
| None | 75 | 261 | |
| Furosemide | 19 | 87 | |
| None | 64 | 179 |
This table presents the data that contributed to significant logistic regressions modeling for the risk of complications associated with dantrolene. The total number in each of these 2 by 2 comparisons differs because the first three variables in Table 5 were significant in the full dataset model and the last two in the reduced dataset model.